Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
GoodRx Holdings, Inc. (GDRX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/09/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/09/2023 |
8-K
| Quarterly results |
| 07/27/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 06/16/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 06/06/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 06/06/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o... |
| 05/10/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/10/2023 |
8-K
| Quarterly results|
Docs:
|
"Three Months Ended March 31, December 31, September 30, June 30, March 31, 2023 2022 2022 2022 2022 Monthly Active Consumers 6.1 5.9 5.8 5.8 6.4 As of March 31, December 31, September 30, June 30, March 31, 2023 2022 2022 2022 2022 Subscription plans 1,007 1,030 1,060 1,133 1,203 GoodRx Holdings, Inc. Condensed Consolidated Balance Sheets Assets Current assets Cash and cash equivalents $ 761,075 $ 757,165 Accounts receivable, net 116,442 117,141 Prepaid expenses and other current assets 29,499 45,380 Total current assets 907,016 919,686 Property and equipment, net 18,767 19,820 Goodwill 412,117 412,117 Intangible assets, net 114,256 119,865 Capitalized software, net 83,047 70,072 Operating lease right-of-use assets 34,916 35,906 Other assets 41,381 27,165 Total assets $ 1,611,500 $ 1,604,..." |
|
| 05/01/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 05/01/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 05/01/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/25/2023 |
8-K
| Quarterly results |
| 03/13/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 03/10/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 10.1% stake in GoodRx Holdings Inc. Class A |
| 02/28/2023 |
8-K
| Quarterly results |
| 02/13/2023 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 9.5% stake in GoodRx Holdings Inc. Class A |
| 02/06/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/16/2022 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 12/09/2022 |
8-K
| Quarterly results |
| 11/10/2022 |
8-K
| Quarterly results |
| 11/08/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/08/2022 |
8-K
| Quarterly results |
| 09/26/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 09/12/2022 |
SC 13G/A
| MORGAN STANLEY reports a 0.5% stake in GoodRx Holdings, Inc. |
| 08/31/2022 |
8-K
| Cost Associated with Exit or Disposal Activities Interactive Data |
| 08/08/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/08/2022 |
8-K
| Quarterly results |
| 06/28/2022 |
8-K/A
| Quarterly results |
| 06/17/2022 |
8-K
| Quarterly results |
| 05/24/2022 |
UPLOAD
| Form UPLOAD - SEC-generated letter: |
| 05/18/2022 |
CORRESP
| Form CORRESP - Correspondence: |
| 05/11/2022 |
UPLOAD
| Form UPLOAD - SEC-generated letter: |
| 05/09/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
|
|
|